Financial reports
10-K
2019 FY
Annual report
27 Feb 20
10-Q
2019 Q3
Quarterly report
7 Nov 19
10-Q
2019 Q2
Quarterly report
7 Aug 19
10-Q
2019 Q1
Quarterly report
9 May 19
10-K
2018 FY
Annual report
7 Mar 19
10-Q
2018 Q3
Quarterly report
7 Nov 18
10-Q
2018 Q2
Quarterly report
8 Aug 18
10-Q
2018 Q1
Quarterly report
9 May 18
10-K
2017 FY
Annual report
14 Mar 18
Current reports
8-K
UCB completes the acquisition of Ra Pharmaceuticals – to deliver differentiated therapies to patients
2 Apr 20
8-K
Other Events
31 Mar 20
8-K
Entry into a Material Definitive Agreement
16 Mar 20
8-K
Other Events
28 Feb 20
8-K
Submission of Matters to a Vote of Security Holders
18 Dec 19
8-K
Other Events
25 Nov 19
8-K
Entry into a Material Definitive Agreement
10 Oct 19
8-K
Other Events
26 Jul 19
8-K
Entry into a Material Definitive Agreement
16 Jul 19
8-K
Submission of Matters to a Vote of Security Holders
12 Jun 19
Registration and prospectus
15-12B
Securities registration termination
13 Apr 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 20
POSASR
Automatic shelf registration (post-effective amendment)
2 Apr 20
POS AM
Prospectus update (post-effective amendment)
2 Apr 20
25-NSE
Exchange delisting
2 Apr 20
424B5
Prospectus supplement for primary offering
24 Jul 19
424B5
Prospectus supplement for primary offering
22 Jul 19
Proxies
DEFA14A
Additional proxy soliciting materials
6 Dec 19
DEFM14A
Proxy related to merger
15 Nov 19
PREM14A
Preliminary proxy related to merger
1 Nov 19
DEFA14A
Additional proxy soliciting materials
10 Oct 19
DEFA14A
Additional proxy soliciting materials
26 Apr 19
DEF 14A
Definitive proxy
26 Apr 19
DEFR14A
Revised proxy
7 May 18
DEFA14A
Additional proxy soliciting materials
27 Apr 18
DEF 14A
Definitive proxy
27 Apr 18
DEF 14A
Definitive proxy
28 Apr 17
Other
EFFECT
Notice of effectiveness
9 Apr 20
EFFECT
Notice of effectiveness
14 Nov 17
CORRESP
Correspondence with SEC
9 Nov 17
UPLOAD
Letter from SEC
9 Nov 17
CT ORDER
Confidential treatment order
26 Oct 16
EFFECT
Notice of effectiveness
25 Oct 16
CORRESP
Correspondence with SEC
21 Oct 16
CORRESP
Correspondence with SEC
21 Oct 16
CORRESP
Correspondence with SEC
14 Oct 16
CORRESP
Correspondence with SEC
13 Oct 16
Ownership